Table 3 Coagulation parameters during ECMO therapy.
From: Acquired factor XIII deficiency in adult patients during ECMO: a prospective observational study
Coagulation parameter | Unit | Minimum | Maximum |
|---|---|---|---|
Platelet count | G/L | 51 (38–70) | 145 (117–195) |
Antithrombin III activity | % | 54 (44–69) | 113 (99–128) |
D-dimer | µg/mL | 1.7 (0.9–4.1) | 21 (7.6–35.2) |
Fibrinogen | mg/dL | 222 (182–369) | 704 (594–900) |
aPTT | Seconds | 30.8 (25.8–33.0) | 59.6 (49.2–75.3) |
Prothrombin time | Seconds | 53.5 (41.0–68.5) | 119 (101–138) |
UFH anti-Xa activity | IU/mL | 0.1 (0.1–0.1) | 0.3 (0.2–0.45) |
FVIII activity | % | 253 (162–34) | 394 (267–450) |
vWF antigen | % | 252 (196–372) | 303 (208–392) |
vWF activity | % | 183 (132–244) | 209 (161–276) |
FVIII/vWF Ag ratio | – | 0.9 (0.7–1.2) | 0.9 (0.7–1.3) |
Von Willebrand factor ratio | – | 0.8 (0.7–0.8) | 0.8 (0.7–0.8) |
